Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (3)
Type
(
1 selected
)
Type
Guidance (757)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (27)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (757)
Apply filters
Showing 71 to 80 of 757
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Lorlatinib for untreated ALK-positive advanced non-small-cell lung cancer
TA909
12 July 2023
12 July 2023
Rimegepant for preventing migraine
TA906
5 July 2023
5 July 2023
Olaparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal cancer after 2 or more courses of platinum-based chemotherapy
TA908
5 July 2023
5 July 2023
Deucravacitinib for treating moderate to severe plaque psoriasis
TA907
28 June 2023
28 June 2023
Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction
TA902
21 June 2023
21 June 2023
Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancer
TA903
21 June 2023
21 June 2023
Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancer
TA904
21 June 2023
21 June 2023
Upadacitinib for previously treated moderately to severely active Crohn's disease
TA905
21 June 2023
21 June 2023
Cemiplimab for treating recurrent or metastatic cervical cancer (terminated appraisal)
TA901
20 June 2023
20 June 2023
Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer
TA898
14 June 2023
14 June 2023
Previous page
1
…
6
7
Current page
8
9
10
…
76
Page
8
of
76
Next page
Results per page
10
25
50
All
Back to top